183 episodes

Podcast by STAT

The Readout Loud STAT

    • Business
    • 4.7 • 234 Ratings

Podcast by STAT

    Episode 182: The FDA star search, more booster debates, & the future of mRNA

    Episode 182: The FDA star search, more booster debates, & the future of mRNA

    STAT Washington correspondent Nicholas Florko joins us to provide an inside look at the eleventh-hour search for a permanent FDA commissioner. We also discuss the latest twist in the debate over Covid-19 vaccine boosters, some upheaval in the world of genome editing, and a little news for parents from one Scott Gottlieb.

    • 33 min
    Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadline

    Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadline

    First, we discuss the scramble to find new leaders for the NIH and FDA, the latest online dustup involving Ginkgo Bioworks, and the growing promise of antiviral treatments for Covid-19. Then, filmmaker Brent Hodge joins us to discuss his documentary "Pharma Bro," which chronicles the trial, conviction, and prolific livestreaming of one Martin Shkreli.

    • 33 min
    Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest

    Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest

    First, we welcome STAT reporter Usha Lee McFarling onto the podcast to discuss her investigation into health equity tourism — how white scholars are colonizing research on health disparities. Then, we "chatty Cathy" a blizzard of biotech news from this week, including Merck's $11 billion acquisition of Acceleron Pharma, a theatrical street protest about the Covid vaccine equity dive, a debate about gene therapy's future, and, finally, why Scott Gottlieb is looking up at Elvira.

    • 28 min
    Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rollout

    Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rollout

    First, STAT's Helen Branswell joins us to discuss the state of the Covid-19 pandemic as we head into another winter. Then, former FDA Commissioner Scott Gottlieb calls in to discuss his new book on how the U.S. got caught off guard and what the government needs to do before the next pandemic hits. We start with a look at the latest news in the life sciences, including the booster debate, Biogen's trouble selling its controversial Alzheimer's drug, and the awkward pairing of beer and face masks.

    • 36 min
    Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

    Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

    Can prosthetic limbs feel real? Is the FDA softening under pressure? And are Rice Krispies Treats admissible in court?

    STAT's Gideon Gil joins us to share the remarkable story of an amputation surgery that makes a phantom limbs feel like the real thing. Then we discuss the FDA's surprising reversal on a new treatment for ALS and whether it signals a sea change within the agency. We start with a look at the latest news in the life sciences, including the debate over Covid-19 vaccine boosters, the future of in-person conferences, and a mysterious sweet-toothed observer at Elizabeth Holmes's fraud trial.

    • 35 min
    Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth

    Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth

    First, STAT's Erin Brodwin joins us to talk about Verily, Google's big-idea life sciences company that is now under pressure to produce some actual products. Then, health care investor Bijan Salehizadeh calls in to discuss the dearth of rapid Covid-19 tests in the U.S. and how industry, regulators, and lawmakers share the blame. We also take a look at the latest news in biotech, including Biogen's troubled launch of Aduhelm, Moderna's long-term scientific ambitions, and a big day for the Waksal brothers.

    • 36 min

Customer Reviews

4.7 out of 5
234 Ratings

234 Ratings

cmc4648 ,

Great reporters

It’s obvious the hosts of this podcast are working reporters, and good ones at that. The show topics are exactly what I want to know about biotech each week. I’m also a big fan of the “chatty Cathy” segment.

Long time in China ,

Excellent

Highly quality podcast

liviayyyyy ,

Best biotech podcast ever

Love love this podcast! Wanted to to find something similar for a long time! I am glad I was able to find this podcast. The hosts are so knowledgeable and articulate.
Good flow, interesting story, and wonderful people! I just want more! Maybe twice a week?

Top Podcasts In Business

You Might Also Like